The association of erythropoietin-stimulating agents and increased risk for AV-fistula dysfunction in hemodialysis patients. A retrospective analysis

BACKGROUND: Patients in maintenance hemodialysis (HD) need a patent vascular access for optimal treatment. The recommended first choice is a native arteriovenous fistula (AVF). Complications of AVF are frequent and include thrombosis, stenosis and infections leading to worsening of dialysis efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wärme, Anna, Hadimeri, Henrik, Nasic, Salmir, Stegmayr, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814716/
https://www.ncbi.nlm.nih.gov/pubmed/33461526
http://dx.doi.org/10.1186/s12882-020-02209-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814716/
https://www.ncbi.nlm.nih.gov/pubmed/33461526
http://dx.doi.org/10.1186/s12882-020-02209-6

Ejemplares similares